India becomes one of the first countries to get Novo Nordisk's weekly basal insulin Awiqli; experts say it offers a new treatment option rather than a replacement for conventional insulin therapy.
Nearly 104 years after daily insulin injections became the standard treatment for diabetes, patients in India now have access to a once-a-week insulin shot.
-copy-29e15046.jpeg?w=600)
